Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)
India flag India · Delayed Price · Currency is INR
35.93
+0.83 (2.36%)
At close: Jun 17, 2026

BOM:524396 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
27.865.587.095.66.98
Depreciation & Amortization
2.723.83.994.294.28
Other Operating Activities
0.070.582.34-0.540.51
Change in Accounts Receivable
107.29-52.86-125.26-133.29100.44
Change in Inventory
-6.58-7.92-13.360.830.51
Change in Accounts Payable
-139.2734.33149.05120.54-152.56
Change in Other Net Operating Assets
1.87-2.740.091.487.64
Operating Cash Flow
-6.05-19.2423.94-1.12-2.2
Capital Expenditures
-2.01-1-0.23-0.11-0.7
Sale of Property, Plant & Equipment
13.38----
Investing Cash Flow
11.37-1-0.23-0.11-0.7
Long-Term Debt Issued
25.490.32-0.580.35
Total Debt Issued
25.490.32-0.580.35
Long-Term Debt Repaid
---0.83--
Total Debt Repaid
---0.83--
Net Debt Issued (Repaid)
25.490.32-0.830.580.35
Other Financing Activities
-0.1-0.37-0.42-0.43-0.41
Financing Cash Flow
25.39-0.05-1.250.15-0.06
Miscellaneous Cash Flow Adjustments
-0---
Net Cash Flow
30.71-20.2822.46-1.07-2.96
Free Cash Flow
-8.05-20.2423.71-1.22-2.9
Free Cash Flow Margin
-2.56%-6.03%5.87%-0.41%-1.29%
Free Cash Flow Per Share
-0.49-1.241.46-0.07-0.18
Cash Interest Paid
0.10.360.40.420.39
Cash Income Tax Paid
4.072.12.42.32.71
Levered Free Cash Flow
-17.18-21.7119.89-0.62-4.6
Unlevered Free Cash Flow
-17.11-21.4820.14-0.36-4.36
Change in Working Capital
-36.7-29.1910.52-10.47-13.97